+++thanks nil_4 more articles from Sciencedirect

[pendyala123]

6.Tuberculosis drug development pipeline: progress and hope
Melvin Spigelman, MDa, Dr Stephen Gillespie, MDb, ,
Lancet, Volume 367, Issue 9514, 18–24 March 2006, Pages 945–947

DOI:

http://dx.doi.org/10.1016/S0140-6736(06)68388-8

Код: Выделить всё

http://www.sciencedirect.com/science/article/pii/S0140673606683888

7.Novel targets for tuberculosis drug discovery
Khisimuzi Mdluli , Melvin Spigelman
Current Opinion in Pharmacology
Volume 6, Issue 5, October 2006, Pages 459–467
Anti-infectives/New Technologies

DOI:

http://dx.doi.org/10.1016/j.coph.2006.06.004

Код: Выделить всё

http://www.sciencedirect.com/science/article/pii/S1471489206001354

8.Opportunities afforded by new drugs for tuberculosis
Gavin J Churchyarda, b, c, , Gerald Friedlandb, d, Katherine Fieldingc, Edward Nardelle
The LAncet-infectious diseases,Volume 10, Issue 6, June 2010, Pages 368–369

DOI:

http://dx.doi.org/10.1016/S1473-3099(10)70095-5

Код: Выделить всё

http://www.sciencedirect.com/science/article/pii/S1473309910700955

9.Tuberculosis: Molecular Basis of Pathogenesis
P.J. Brennan
Encyclopedia of Microbiology (Third Edition)
2009, Pages 333–339

DOI:

http://dx.doi.org/10.1016/B978-012373944-5.00198-X

Код: Выделить всё

http://www.sciencedirect.com/science/article/pii/B978012373944500198X

[nil]

no 6.....

[nil]

no 9......

[nil]

no 7 and 8 enjoy......